Jim Kerr is Chief of Manufacturing and Product Development at Design Therapeutics. Jim brings more than 30 years of experience in managing chemistry, manufacturing, and controls (CMC) and product development operations for a broad range of NCE types and product dosage forms. Previously, Jim led product development and manufacturing activities at Auspex and Teva, where he oversaw the manufacturing launch of AUSTEDO® (deutetrabenazine). Throughout his career, he has managed product development, analytical and manufacturing programs for several companies, including Pfizer Inc, Chugai Pharmaceutical Co, and 3M Company, resulting in the commercialization of Actemra® (tocilizumab), Proventil HFA (albuterol sulfate), QVAR® (beclomethasone dipropionate), and Maxair™ Autohaler™. Jim completed his Bachelor of Science in Chemistry at the University of Minnesota-Duluth.